Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-18 4:56 pm Purchase |
2023-08-10 | 13G | Gracell Biotechnologies Inc. GRCL |
Vivo Opportunity Fund Holdings, L.P. | 38,152,030 7.800% |
38,152,030 (New Position) |
Filing History |
| 2023-07-14 4:30 pm Purchase |
2023-07-11 | 13G | Unicycive Therapeutics, Inc. UNCY |
Vivo Opportunity Fund Holdings, L.P. | 59,961,729 9.990% |
59,961,729 (New Position) |
Filing History |
| 2023-06-28 4:30 pm Purchase |
2023-06-21 | 13G | Clene Inc. CLNN |
Vivo Opportunity Fund Holdings, L.P. | 886,890 9.990% |
886,890 (New Position) |
Filing History |
| 2023-06-22 4:30 pm Purchase |
2023-06-12 | 13G | Delcath Systems, Inc. DCTH |
Vivo Opportunity Fund Holdings, L.P. | 4,880,741 9.990% |
4,880,741 (New Position) |
Filing History |
| 2023-06-01 5:00 pm Purchase |
2023-05-25 | 13D | Soleno Therapeutics, Inc. SLNO |
Vivo Opportunity Fund Holdings, L.P. | 8,418,093 50.800% |
8,418,093 (New Position) |
Filing History |
| 2023-05-15 5:02 pm Purchase |
2023-05-08 | 13G | Soleno Therapeutics, Inc. SLNO |
Vivo Opportunity Fund Holdings, L.P. | 8,418,093 19.990% |
8,418,093 (New Position) |
Filing History |